What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.89%
Annual Rate
CNY 0.40Paid annual
Payout Ratio
74.1%Moderate
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.69BCNY
1.29B · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
83.43x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Revenue (TTM)
964.00MCNY
143.36M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
10.94%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Beta
0.8420x
vs all stocks
Updated Aug 21, 2026
52-Week Change
11.77%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
8.69BCNY
1.29B · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
6.71BCNY
997.80M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
83.43x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Forward P/E
41.33x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Price to Sales (TTM)
9.06x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Price to Book (MRQ)
2.73x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to Revenue
6.96x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to EBITDA
49.44x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 34.61×.Updated Aug 21, 2026
Gross Margin
58.10%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 54.7%.Updated Aug 21, 2026
Profit Margin
10.94%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Margin
12.08%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Assets (TTM)
1.23%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Equity (TTM)
3.32%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Revenue (TTM)
964.00MCNY
143.36M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
4.90CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
38.00%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Gross Profit (TTM)
527.33MCNY
78.42M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
193.87MCNY
28.83M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
105.45MCNY
15.68M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
512.00%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
84.15MCNY
12.51M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
2.66MCNY
394.83K · vs all stocks (USD)
Updated Aug 21, 2026
Trailing Annual Dividend Rate
0.4000CNYUpdated Aug 21, 2026
Trailing Annual Dividend Yield
0.89%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
74.07%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Revenue
900.23MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
404.38MCNYFY2025 · Dec 31, 2025
Gross Profit
495.85MCNYFY2025 · Dec 31, 2025
Operating Income
54.51MCNY
8.11M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
91.05MCNYFY2025 · Dec 31, 2025
Income Tax Expense
4.97MCNYFY2025 · Dec 31, 2025
Net Income
86.08MCNYFY2025 · Dec 31, 2025
EBIT
99.80MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
194.12MCNYFY2025 · Dec 31, 2025
Research & Development
225.89MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
220.71MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.29MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.12MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
8.75MCNYFY2025 · Dec 31, 2025
Net Income from Continuing Operations
86.08MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
16.95MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-43.85MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
344.31MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
86.08MCNYFY2025 · Dec 31, 2025
Stock-based Compensation
5.71MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
20.80MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-28.54MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-67.11MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-60.80MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-695.99MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.02BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
267.76MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
202.40MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-500.58MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-84.71MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-49.11MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-432.00MCNYFY2025 · Dec 31, 2025
Shares Outstanding
193.87MSharesUpdated Aug 21, 2026
Float Shares
83.73MSharesUpdated Aug 21, 2026
% Held by Insiders
63.69%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
6.12%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
1.80BCNY
267.30M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
9.32CNYUpdated Aug 21, 2026
Total Debt (MRQ)
59.25MCNY
8.81M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.0186x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Current Ratio (MRQ)
7.50x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
16.48CNYUpdated Aug 21, 2026
Total Assets
3.58BCNY
533.06M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.40BCNYFY2025 · Dec 31, 2025
Total Liabilities
423.77MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.18BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
53.88MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
369.88MCNYFY2025 · Dec 31, 2025
Cash
313.99MCNYFY2025 · Dec 31, 2025
Cash Equivalents
38.48MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
352.47MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
1.49BCNYFY2025 · Dec 31, 2025
Accounts Receivable
194.27MCNYFY2025 · Dec 31, 2025
Inventory
326.73MCNYFY2025 · Dec 31, 2025
Accounts Payable
108.78MCNYFY2025 · Dec 31, 2025
Short-term Debt
72.93MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
258.29KCNYFY2025 · Dec 31, 2025
Long-term Debt
17.09MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
7.04MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
193.87MCNYFY2025 · Dec 31, 2025
Retained Earnings
107.91MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.16BCNY
470.05M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
40.54MCNYFY2025 · Dec 31, 2025
52-Week Low
35.21CNYUpdated Aug 21, 2026
52-Week High
81.80CNYUpdated Aug 21, 2026
52-Week Change
11.77%
vs all stocks
Updated Aug 21, 2026
Beta
0.8420x
vs all stocks
Updated Aug 21, 2026
50-Day MA
54.40CNYUpdated Aug 21, 2026
200-Day MA
48.71CNYUpdated Aug 21, 2026
Avg 10-Day Volume
4.15MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
4.79MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
0.5400CNYUpdated Aug 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 7.5×, higher than 95% of its Scientific & Technical Instruments peers (median 3.16×)Significant
Current ratio: 7.50Industry median: 3.16Industry P95: 6.33Peers compared: 32.00